179 related articles for article (PubMed ID: 6390086)
1. Plasma glucagon suppressibility after oral glucose in obese subjects with normal and impaired glucose tolerance.
Borghi VC; Wajchenberg BL; Cesar FP
Metabolism; 1984 Dec; 33(12):1068-74. PubMed ID: 6390086
[TBL] [Abstract][Full Text] [Related]
2. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
Enoki S; Mitsukawa T; Takemura J; Nakazato M; Aburaya J; Toshimori H; Matsukara S
Diabetes Res Clin Pract; 1992 Jan; 15(1):97-102. PubMed ID: 1541241
[TBL] [Abstract][Full Text] [Related]
3. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.
Matsumoto K; Miyake S; Yano M; Ueki Y; Yamaguchi Y; Akazawa S; Tominaga Y
Diabetes Care; 1997 Oct; 20(10):1562-8. PubMed ID: 9314636
[TBL] [Abstract][Full Text] [Related]
4. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
5. Plasma level of glucagon-like peptide 1 in obese Egyptians with normal and impaired glucose tolerance.
Hussein MS; Abushady MM; Refaat S; Ibrahim R
Arch Med Res; 2014 Jan; 45(1):58-62. PubMed ID: 24321596
[TBL] [Abstract][Full Text] [Related]
6. Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity.
Salera M; Giacomoni P; Pironi L; Cornia G; Capelli M; Marini A; Benfenati F; Miglioli M; Barbara L
J Clin Endocrinol Metab; 1982 Aug; 55(2):329-36. PubMed ID: 7045154
[TBL] [Abstract][Full Text] [Related]
7. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
Rask E; Olsson T; Söderberg S; Holst Jj Jj; Tura A; Pacini G; Ahrén B
Metabolism; 2004 May; 53(5):624-31. PubMed ID: 15131768
[TBL] [Abstract][Full Text] [Related]
8. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
Calanna S; Piro S; Di Pino A; Maria Zagami R; Urbano F; Purrello F; Maria Rabuazzo A
Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781
[TBL] [Abstract][Full Text] [Related]
9. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations.
Golay A; Swislocki AL; Chen YD; Jaspan JB; Reaven GM
J Clin Endocrinol Metab; 1986 Aug; 63(2):481-4. PubMed ID: 3522620
[TBL] [Abstract][Full Text] [Related]
10. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
[TBL] [Abstract][Full Text] [Related]
11. Pattern of obesity and insulin, glucagon, sex hormone binding globulin and lipids in obese Arab women.
Emara MK; Saadah A; Hassan M; Moussa M; Hourani H
Diabetes Res; 1989 Apr; 10(4):175-81. PubMed ID: 2692944
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin response to glucose before and after prolonged fasting in lean and obese non-diabetic subjects.
Verrillo A; de Teresa A; Martino C; di Chiara G; Verrillo L
Regul Pept; 1988 Jun; 21(3-4):185-95. PubMed ID: 2901133
[TBL] [Abstract][Full Text] [Related]
13. [Changes in plasma glucagon concentration in patients with diabetes mellitus and its clinical significance].
Tang S
Zhonghua Yi Xue Za Zhi; 1992 Apr; 72(4):222-4, 255. PubMed ID: 1327451
[TBL] [Abstract][Full Text] [Related]
14. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
15. Effects of insulin on the response of immunoreactive glucagon to an intravenous glucose load in human diabetes.
Yamamoto T; Raskin P; Aydin I; Unger R
Metabolism; 1979 May; 28(5):568-74. PubMed ID: 449698
[TBL] [Abstract][Full Text] [Related]
16. Basal alpha-cell up-regulation in obese insulin-resistant adolescents.
Weiss R; D'Adamo E; Santoro N; Hershkop K; Caprio S
J Clin Endocrinol Metab; 2011 Jan; 96(1):91-7. PubMed ID: 20843946
[TBL] [Abstract][Full Text] [Related]
17. Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance.
Ehrmann DA; Breda E; Cavaghan MK; Bajramovic S; Imperial J; Toffolo G; Cobelli C; Polonsky KS
Diabetologia; 2002 Apr; 45(4):509-17. PubMed ID: 12032626
[TBL] [Abstract][Full Text] [Related]
18. The gastro-entero-pancreatic hormone response to fasting in obesity.
Andrews WJ; Henry RW; Alberti KG; Buchanan KD
Diabetologia; 1981 Nov; 21(5):440-5. PubMed ID: 7028557
[TBL] [Abstract][Full Text] [Related]
19. Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion.
Abdul-Ghani M; DeFronzo RA
J Clin Endocrinol Metab; 2007 May; 92(5):1778-84. PubMed ID: 17327375
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms Regulating Insulin Response to Intragastric Glucose in Lean and Non-Diabetic Obese Subjects: A Randomized, Double-Blind, Parallel-Group Trial.
Meyer-Gerspach AC; Cajacob L; Riva D; Herzog R; Drewe J; Beglinger C; Wölnerhanssen BK
PLoS One; 2016; 11(3):e0150803. PubMed ID: 26942445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
